THINK Surgical Appoints Rick McDowell as Vice President, Sales
Procept Biorobotics Corp PRCT
$18.22
▲ +5.62%
(+$0.97)
⬆️ Above Yest. High
Open
$17.37
Prev Close
$17.25
Day Range
$16.80 – $18.67
52W Range
$16.67 – $38.11
Market Cap
$1.04B
Beta
0.92
EPS (TTM)
$-1.95
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2021-09-15 |
| Shares Out. | 56,920,000 |
| Website | procept-biorobotics.com/ ↗ |
| Phone | 18887167274 |
| Employees | 888 |
| Revenue | $94.5M |
| Gross Profit | $62.4M |
| Net Income | -$26.9M |
| Free Cash Flow | -$84.9M |
| Total Assets | $479.4M |
| Total Liabilities | $139.3M |
| Equity | $340.1M |
About Procept Biorobotics Corp
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
Procept Biorobotics Corp is a publicly traded company under the ticker symbol PRCT on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
21 analysts (2026-09-01)